HTG Molecular Diagnostics (HTGMQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock HTGMQ vs. OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, VLTO, FTV, TER, and RVTYShould you be buying HTG Molecular Diagnostics stock or one of its competitors? The main competitors of HTG Molecular Diagnostics include OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), Veralto (VLTO), Fortive (FTV), Teradyne (TER), and Revvity (RVTY). These companies are all part of the "measuring and control equipment" industry. HTG Molecular Diagnostics vs. OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Veralto Fortive Teradyne Revvity OmniLit Acquisition (NASDAQ:OLITW) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, community ranking, earnings, profitability, dividends, media sentiment and analyst recommendations. Is OLITW or HTGMQ more profitable? Company Net Margins Return on Equity Return on Assets OmniLit AcquisitionN/A N/A N/A HTG Molecular Diagnostics N/A N/A N/A Does the MarketBeat Community prefer OLITW or HTGMQ? OmniLit Acquisition and HTG Molecular Diagnostics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformOmniLit AcquisitionN/AN/AHTG Molecular DiagnosticsN/AN/A Does the media prefer OLITW or HTGMQ? In the previous week, OmniLit Acquisition's average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score. Company Overall Sentiment OmniLit Acquisition Neutral HTG Molecular Diagnostics Neutral Which has better valuation and earnings, OLITW or HTGMQ? OmniLit Acquisition has higher earnings, but lower revenue than HTG Molecular Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmniLit AcquisitionN/AN/AN/AN/AN/AHTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A SummaryHTG Molecular Diagnostics beats OmniLit Acquisition on 1 of the 1 factors compared between the two stocks. Get HTG Molecular Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for HTGMQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HTGMQ vs. The Competition Export to ExcelMetricHTG Molecular DiagnosticsAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$4.16B$5.56B$7.82BDividend YieldN/A0.57%5.11%4.22%P/E RatioN/A27.2922.5718.48Price / SalesN/A4.23395.64103.60Price / CashN/A36.1538.1834.62Price / BookN/A1.686.774.25Net Income-$21.59M-$83.57M$3.22B$248.23M HTG Molecular Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.03-23.6%N/A-71.8%$0.00N/A0.003High Trading VolumePRENWPrenetics GlobalN/A$0.01flatN/A+24.0%$0.00$25.56M0.001Short Interest ↓Negative NewsGap DownQSIAWQuantum-SiN/A$0.33-5.7%N/A+52.2%$0.00$3.06M0.00150SMAPWSportsMap Tech AcquisitionN/A$0.06-8.0%N/AN/A$0.00N/A0.00N/ATTTrane Technologies3.9378 of 5 stars$332.92+3.3%$405.31+21.7%+20.8%$74.67B$19.84B29.5939,000Earnings ReportAnalyst UpgradeNews CoveragePositive NewsGap UpKEYSKeysight Technologies4.2044 of 5 stars$135.28+2.6%$181.33+34.0%-1.7%$22.79B$5.02B38.6515,000Short Interest ↑Analyst RevisionPositive NewsVLTOVeralto2.9406 of 5 stars$89.04+2.1%$111.10+24.8%+2.5%$22.09B$5.19B26.6616,000Earnings ReportShort Interest ↑News CoveragePositive NewsFTVFortive4.6297 of 5 stars$66.04+3.2%$81.92+24.0%-7.4%$21.78B$6.23B27.9818,000Earnings ReportNews CoveragePositive NewsTERTeradyne4.932 of 5 stars$71.29+2.1%$118.94+66.8%-36.2%$11.47B$2.82B21.416,500Earnings ReportAnalyst ForecastBuyback AnnouncementOptions VolumeAnalyst RevisionRVTYRevvity3.7132 of 5 stars$92.44+3.0%$130.50+41.2%-8.9%$11.11B$2.76B41.8316,700Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionNews Coverage Related Companies and Tools Related Companies OLITW Alternatives PRENW Alternatives QSIAW Alternatives SMAPW Alternatives TT Alternatives KEYS Alternatives VLTO Alternatives FTV Alternatives TER Alternatives RVTY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HTGMQ) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HTG Molecular Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HTG Molecular Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.